Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Agmatine and Norepinephrine

supplement:

Agmatine

Research Papers that Mention the Interaction

In addition, agmatine treatment in control mice increased noradrenaline , serotonin, and dopamine levels, CREB phosphorylation, mature BDNF and synaptotagmin I immunocontents, and reduced pro-BDNF immunocontent in the hippocampus.
Molecular Neurobiology  •  2015  |  View Paper
These results indicate that agmatine prevents the ischemic renal injury by sympathoinhibitory effect probably via I(1) receptors in central nervous system and by suppressing the norepinephrine overflow through alpha(2) or I(1) receptors on sympathetic nerve endings.
European journal of pharmacology  •  2009  |  View Paper
Agmatine was found to be ineffective on contractile responses of noradrenaline in electrically driven ventricular strips of frog heart.
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology  •  2006  |  View Paper
Agmatine decreased MHPG levels at 300 and 400 mg/kg, however it decreased norepinephrine levels only at the higher dose.
Life sciences  •  2003  |  View Paper
In contractions induced by exogenous drugs, agmatine potentiated, only in the prostatic segment, the effects of noradrenaline (norepinephrine) or ATP; it also enhanced the effect of low concentrations of KCl and blocked the maximum effect of the higher concentrations.
The Journal of pharmacy and pharmacology  •  2003  |  View Paper
Agmatine (6 and 60 mg/kg), an endogenous agonist at I1-binding sites, reduced noradrenaline overflow (−36 or 53%), even under α2-adrenoceptor blockade.
Journal of Pharmacology and Experimental Therapeutics  •  2003  |  View Paper
Agmatine reduces noradrenaline release in pithed SHR while α2‐adrenoceptors are irreversibly blocked with phenoxybenzamine, but not while I1‐binding sites are selectively blocked with AGN192403.
This suggests that agmatine may modulate noradrenaline release in the same way that clonidine does, i.e. via imidazoline binding sites; this involves a reduction in sympathetic tone which in turn reduces blood pressure and heart rate.
British journal of pharmacology  •  2002  |  View Paper
In vitro, agmatine failed to change the firing rate of LC neurones nor did it antagonize the inhibitory effect of noradrenaline on these cells.
Neuroscience Letters  •  1996  |  View Paper